financetom
Business
financetom
/
Business
/
Scholar Rock Plans $275 Million Securities Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scholar Rock Plans $275 Million Securities Sale
Oct 7, 2024 7:24 PM

05:02 PM EDT, 10/07/2024 (MT Newswires) -- Scholar Rock Holding ( SRRK ) said Monday it plans to sell common shares and pre-funded warrants worth $275 million in an underwritten public offering.

Underwriters have been granted a 30-day option to buy 15% additional shares, the company said.

Net proceeds will be allocated to support current and future clinical programs along with working capital and other general corporate purposes, it added.

Price: 34.03, Change: -0.25, Percent Change: -0.73

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Springworks Therapeutics Agrees to $47-Per-Share Takeover Offer From Germany's Merck
Update: Springworks Therapeutics Agrees to $47-Per-Share Takeover Offer From Germany's Merck
May 25, 2025
04:01 AM EDT, 04/28/2025 (MT Newswires) -- (Updates to add more information in the third, fourth, and sixth paragraphs.) SpringWorks Therapeutics ( SWTX ) has agreed to be acquired by German technology firm Merck KGaA for $47 per share in cash, the companies said in a joint statement Monday. The consideration represents about $3.9 billion in equity value, or $3.4...
UroGen Pharma Reports Nearly 4-Year Response for Urothelial Cancer Therapy -- Shares Up Pre-Bell
UroGen Pharma Reports Nearly 4-Year Response for Urothelial Cancer Therapy -- Shares Up Pre-Bell
May 25, 2025
04:14 AM EDT, 04/28/2025 (MT Newswires) -- UroGen Pharma ( URGN ) stock was up 18% in premarket activity Monday, a day after it reported long-term data from a follow-up analysis of its phase 3 trial of urothelial cancer therapy Jelmyto showing treatment response duration of nearly four years. The company said the study showed that 41 patients treated had...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Abbott Laboratories Says Investigational Pacemaker Shows Safety, Performance
Abbott Laboratories Says Investigational Pacemaker Shows Safety, Performance
May 25, 2025
04:09 AM EDT, 04/28/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Sunday its investigational, leadless Aveir Conduction System Pacing device showed safety and performance in a clinical feasibility study. The device delivers conduction pacing to the heart's left bundle branch area by mimicking the heart's electrical rhythm, the company said. Abbott also recently started enrolling patients in a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved